| Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study. | Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study.
Zhang Y, Zhao Y, Zhang J, Gao Y, Gao X, Li S, Chang C, Yang G. | 10/30/2024 |
| Elevated levels of damage-associated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis. | Elevated levels of damage-associated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis.
De Luca G, Goette NP, Lev PR, Baroni Pietto MC, Marin Oyarzún CP, Castro Ríos MA, Moiraghi B, Sackmann F, Kamiya LJ, Verri V, Caula V, Fernandez V, Vicente A, Pose Cabarcos J, Caruso V, Camacho MF, Larripa IB, Khoury M, Marta RF, Glembotsky AC, Heller PG., Free PMC Article | 10/22/2024 |
| Usp14 deficiency removes alpha-synuclein by regulating S100A8/A9 in Parkinson's disease. | Usp14 deficiency removes α-synuclein by regulating S100A8/A9 in Parkinson's disease.
Ding L, Lu L, Zheng S, Zhang Z, Huang X, Ma R, Zhang M, Xu Z, Chen M, Guo Z, Zhu S, Gong J, Mao H, Zhang W, Xu P., Free PMC Article | 09/4/2024 |
| Association Between Clinicopathological Parameters and S100A8/A9 Expression According to Smoking History in Patients With Non-small Cell Lung Cancer. | Association Between Clinicopathological Parameters and S100A8/A9 Expression According to Smoking History in Patients With Non-small Cell Lung Cancer.
Cho SB, Kim IK, Yeo CD, Lee SH., Free PMC Article | 03/29/2024 |
| Serum S100A8/A9 and MMP-9 levels are elevated in systemic lupus erythematosus patients with cognitive impairment. | Serum S100A8/A9 and MMP-9 levels are elevated in systemic lupus erythematosus patients with cognitive impairment.
Muñoz-Grajales C, Barraclough ML, Diaz-Martinez JP, Su J, Bingham K, Kakvan M, Kretzmann RP, Tartaglia MC, Ruttan L, Choi MY, Appenzeller S, Marzouk S, Bonilla D, Katz P, Beaton D, Green R, Gladman DD, Wither J, Touma Z., Free PMC Article | 02/15/2024 |
| Forkhead box A1 induces angiogenesis through activation of the S100A8/p38 MAPK axis in cutaneous wound healing. | Forkhead box A1 induces angiogenesis through activation of the S100A8/p38 MAPK axis in cutaneous wound healing.
Zhou Z, Zou M, Chen H, Zhu F, Wang T, Huang X. | 12/15/2023 |
| Decreased expression of S100A8/A9 in V30M related ATTRv amyloidosis. | Decreased expression of S100A8/A9 in V30M related ATTRv amyloidosis.
Moreira J, Martins S, Saraiva M, Saraiva MJ. | 11/3/2023 |
| S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy. | S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy.
Razmkhah F, Kim S, Lim S, Dania AJ, Choi J., Free PMC Article | 09/18/2023 |
| CD74 Promotes a Pro-Inflammatory Tumor Microenvironment by Inducing S100A8 and S100A9 Secretion in Pancreatic Cancer. | CD74 Promotes a Pro-Inflammatory Tumor Microenvironment by Inducing S100A8 and S100A9 Secretion in Pancreatic Cancer.
Hong WC, Lee DE, Kang HW, Kim MJ, Kim M, Kim JH, Fang S, Kim HJ, Park JS., Free PMC Article | 08/31/2023 |
| Mutation-Driven S100A8 Overexpression Confers Aberrant Phenotypes in Type 1 CALR-Mutated MPN. | Mutation-Driven S100A8 Overexpression Confers Aberrant Phenotypes in Type 1 CALR-Mutated MPN.
Wang YH, Chen YJ, Lai YH, Wang MC, Chen YY, Wu YY, Yang YR, Tsou HY, Li CP, Hsu CC, Huang CE, Chen CC., Free PMC Article | 08/23/2023 |
| S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes. | S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes.
Lin C, Garcia-Gerique L, Bonner EE, Mastio J, Rosenwasser M, Cruz Z, Lawler M, Bernabei L, Muthumani K, Liu Q, Poncz M, Vogl T, Törngren M, Eriksson H, Vogl DT, Gabrilovich DI, Nefedova Y., Free PMC Article | 08/9/2023 |
| Identification of S100A8 as a common diagnostic biomarkers and exploring potential pathogenesis for osteoarthritis and metabolic syndrome. | Identification of S100A8 as a common diagnostic biomarkers and exploring potential pathogenesis for osteoarthritis and metabolic syndrome.
Huang X, Liu J, Huang W., Free PMC Article | 08/3/2023 |
| S100A8 gene copy number and protein expression in breast cancer: associations with proliferation, histopathological grade and molecular subtypes. | S100A8 gene copy number and protein expression in breast cancer: associations with proliferation, histopathological grade and molecular subtypes.
Børkja MLB, Giambelluca MS, Ytterhus B, Prestvik WS, Bjørkøy G, Bofin AM., Free PMC Article | 07/25/2023 |
| S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia. | S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia.
Liao WC, Chen CT, Tsai YS, Wang XY, Chang YT, Wu MS, Chow LP., Free PMC Article | 06/9/2023 |
| S100A8 and S100A9 in Cancer. | S100A8 and S100A9 in Cancer.
Chen Y, Ouyang Y, Li Z, Wang X, Ma J. | 05/22/2023 |
| New Insights into the Impact of Human Papillomavirus on Oral Cancer in Young Patients: Proteomic Approach Reveals a Novel Role for S100A8. | New Insights into the Impact of Human Papillomavirus on Oral Cancer in Young Patients: Proteomic Approach Reveals a Novel Role for S100A8.
Miranda-Galvis M, Carneiro Soares C, Moretto Carnielli C, Ramalho Buttura J, Sales de Sá R, Kaminagakura E, Marchi FA, Paes Leme AF, Lópes Pinto CA, Santos-Silva AR, Moraes Castilho R, Kowalski LP, Squarize CH., Free PMC Article | 05/19/2023 |
| Toward an understanding of the conformational plasticity of S100A8 and S100A9 Ca[2+]-binding proteins. | Toward an understanding of the conformational plasticity of S100A8 and S100A9 Ca(2+)-binding proteins.
Polakowska M, Steczkiewicz K, Szczepanowski RH, Wysłouch-Cieszyńska A., Free PMC Article | 05/17/2023 |
| Expression of S100A8 protein on B cells is associated with disease activity in patients with systemic lupus erythematosus. | Expression of S100A8 protein on B cells is associated with disease activity in patients with systemic lupus erythematosus.
Kitagori K, Oku T, Wakabayashi M, Nakajima T, Nakashima R, Murakami K, Hirayama Y, Ishihama Y, Ohmura K, Morinobu A, Mimori T, Yoshifuji H., Free PMC Article | 05/17/2023 |
| S100-A8/A9 activated TLR4 in renal tubular cells to promote ischemia-reperfusion injury and fibrosis. | S100-A8/A9 activated TLR4 in renal tubular cells to promote ischemia-reperfusion injury and fibrosis.
Huang J, Shi L, Xia Y, Zhu J, Zha H, Wu X, Song Z. | 04/26/2023 |
| S100A8 alarmin supports IL-6 and metalloproteinase-9 production by fibroblasts in the synovial microenvironment of peripheral spondyloarthritis. | S100A8 alarmin supports IL-6 and metalloproteinase-9 production by fibroblasts in the synovial microenvironment of peripheral spondyloarthritis.
Arias JL, Funes SC, Blas R, Callegari E, Eliçabe RJ, Páez MD, Munarriz A, Pardo-Hidalgo R, Tamashiro H, Di Genaro MS., Free PMC Article | 02/4/2023 |
| The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study. | The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study.
d'Angelo DM, Attanasi M, Di Donato G, Lapergola G, Flacco M, Chiarelli F, Altobelli E, Breda L., Free PMC Article | 02/4/2023 |
| Intracellular calprotectin (S100A8/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma. | Intracellular calprotectin (S100A8/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma.
Argyris PP, Saavedra F, Malz C, Stone IA, Wei Y, Boyle WS, Johnstone KF, Khammanivong A, Herzberg MC., Free PMC Article | 02/4/2023 |
| S100A8 enhances IL-1beta production from nasal epithelial cells in eosinophilic chronic rhinosinusitis. | S100A8 enhances IL-1β production from nasal epithelial cells in eosinophilic chronic rhinosinusitis.
Nakatani A, Tsuda T, Maeda Y, Hayama M, Okuzaki D, Obata S, Kishikawa T, Takeda K, Inohara H. | 01/28/2023 |
| Inflammatory markers S100A8/A9 and metabolic alteration for evaluating signs of early phase toxicity of anticancer agent treatment. | Inflammatory markers S100A8/A9 and metabolic alteration for evaluating signs of early phase toxicity of anticancer agent treatment.
Morikawa-Ichinose T, Fujimura Y, Kumazoe M, Onda H, Miura D, Tachibana H. | 01/14/2023 |
| Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subset. | Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subset.
Böttcher M, Panagiotidis K, Bruns H, Stumpf M, Völkl S, Geyh S, Dietel B, Schroeder T, Mackensen A, Mougiakakos D., Free PMC Article | 11/5/2022 |